. Author manuscript; available in PMC: 2019 Jun 1.

Published in final edited form as: Biochim Biophys Acta. 2018 Apr 3;1860(6):1414–1423. doi: 10.1016/j.bbamem.2018.03.021

Table 3.

Box-modeled XR data.

Sample	«Tails»			«Headgroups»			Alipid [Å²]/ΔAlipid	Lipid-to-drug ratio
Sample	l_T (Å)	ρ_T (e⁻/Å³)	extra e⁻	l_H (Å)	ρ_H (e⁻/Å³)	extra e⁻	Alipid [Å²]/ΔAlipid	Lipid-to-drug ratio
DPPG	16.5	0.312	–	8.3	0.477	–	47/−	N/A
+ C1	13	0.313	0	9.1	0.451	61±5	54/0.14	7.13
+ C2	11.6	0.308	0	8.7	0.448	108±6	69/0.46	4.47
+ C3	15.3	0.316	142±7	8.7	0.455	208±8	82/0.75	1.55
+ C4	12.1	0.381	167±8	6	0.438	82±5	92/0.95	2.33
+ C5	15.5	0.372	283±10	8.8	0.422	188±8	94/1.00	1.33
+ C1_dec	11.0	0.340	96±6	7.9	0.394	134±7	94/1.00	2.7
+ CGS	12.6	0.295	34±3	8.2	0.460	135±7	78/0.66	4.3

Subscripts: T – alkyl chains/“tails”; H- headgroups